Intravenous contrast ultrasound in gynecology

In conclusion, the qualitative use of CnTI-SonoVue® technology has improved our confidence in excluding pelvic malignancy. Furthermore, the quantitative assessment seems to be a promising tool for a better distinction between malignant and benign adnexal tumors.